Komori
Yokowo (6800) · InitiativeRestated

Integrated management of the R&D division and open innovation

First written in FY2017-Q1. 21 of 31 entries say "Restated". Latest entry: FY2027-H1.

31entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017-Q1 – FY2019-Q2RestatedFY2020-Q2 – FY2021-Q22016: 220162017: 320172018: 420182019: 220192020: 320202021: 320212022: 320222023: 420232024: 320242025: 220252026: 22026
Same theme, other companies
New-Business Creation Through Integrated R&D Operations and Open InnovationA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2027-H1RestatedAnnual report

    「The Group’s total research and development expenses for the current interim consolidated accounting period were ¥3,071 million. There were no material changes in the Group’s research and development activities during the current interim consolidated accounting period.」

    The company recognized ¥3,071 million in research and development expenses and states that there were no material changes in its research and development activities.
  2. FY2026AdvancedAnnual report

    「The total R&D expenses incurred by the Group during the current consolidated fiscal year, including personnel expenses and other expenses, amounted to ¥5,731 million.」

    R&D expenses increased from ¥5,007 million in the previous fiscal year to ¥5,731 million. In addition to R&D centred on its core technologies, the company is developing optoelectronic fusion devices and medical equipment.
  3. FY2026-H1RestatedAnnual report

    「The total R&D expenses incurred by the Group during the current interim consolidated accounting period amounted to ¥2,658 million. There were no material changes in the Group's R&D activities during the current interim consolidated accounting period.」

    The company stated that there were no material changes in its R&D activities and disclosed R&D expenses of ¥2,658 million for the current interim consolidated accounting period.
  4. FY2025AdvancedAnnual report

    「Based on the Group's Companywide Growth Strategy, the Group has pursued R&D activities aimed at developing new technologies and products, with the R&D Department, the technology departments of the business divisions and local development centres working together. The focus has been on developing products with higher levels of technological integration and added value, centred on the Group's core technologies of antenna technology, semiconductor applications, microwave (high-frequency) technology, surface modification materials technology, micro-precision machining technology and photolithography (MEMS) technology.」

    The company continues to conduct R&D centred on its core technologies, and R&D expenses increased to ¥5,007 million.
  5. FY2025-H1RestatedAnnual report

    「The total R&D expenses incurred by the Group during the current interim consolidated accounting period amounted to ¥2,436 million. There were no material changes in the Group's R&D activities during the current interim consolidated accounting period.」

    The company recorded R&D expenses of ¥2,436 million and stated that there were no material changes in its R&D activities.
  6. FY2024AdvancedAnnual report

    「During the current consolidated fiscal year, the Group made capital investments associated with the start of operations at the MP Center at the Tomioka Plant, as well as investments in mass production and development in each business segment.」

    The MP Center, completed in March 2023, began operations, and capital investment was made in facilities for R&D and product development.
  7. FY2024-Q3RestatedAnnual report

    「The total R&D expenses incurred by the Group during the first nine months of the current consolidated cumulative period amounted to ¥3,356 million. There were no material changes in the Group's R&D activities during the first nine months of the current consolidated cumulative period.」

    The company recorded R&D expenses of ¥3,356 million and stated that there were no material changes in its R&D activities.
  8. FY2024-Q2RestatedAnnual report

    「The total R&D expenses incurred by the Group during the first half of the current consolidated cumulative period amounted to ¥2,194 million. There were no material changes in the Group's R&D activities during the first half of the current consolidated cumulative period.」

    The company recorded R&D expenses of ¥2,194 million and stated that there were no material changes in its R&D activities.
  9. FY2024-Q1AdvancedAnnual report

    「The increase in property, plant and equipment was mainly due to the introduction of production equipment associated with the start of operations at the MP Center new technology building constructed at a plant in Japan.」

    The MP Center new technology building completed in March 2023 began operations, and production equipment was installed.
  10. FY2023AchievedAnnual report

    「Using funds raised through the capital increase, the company will promote basic research that provides the foundation for long-term growth, centred on the MP Center new technology building completed in March 2023. It will further strengthen its core technologies, including micro-precision machining technology and microwave (high-frequency) technology.」

    The MP Center new technology building planned for the fiscal year ending March 2022 was completed in March 2023 and designated as a base for basic research.
  11. FY2023-Q3RestatedAnnual report

    「The total R&D expenses incurred by the Group during the first nine months of the current consolidated cumulative period amounted to ¥3,247 million. There were no material changes in the Group's R&D activities during the first nine months of the current consolidated cumulative period.」

    The company recorded R&D expenses of ¥3,247 million and stated that there were no material changes in its R&D activities.
  12. FY2023-Q2AdvancedAnnual report

    「Cash flow from investing activities amounted to an outflow of ¥2,916 million, an increase of ¥660 million from the same period of the previous year, mainly due to outflows of ¥2,003 million for the acquisition of property, plant and equipment, including construction of the MP Center new technology building in Japan, and ¥484 million for the acquisition of shares in an affiliated company.」

    For the MP Center new technology building, which was scheduled for completion in December 2022, the company disclosed ¥2,003 million in spending on the acquisition of property, plant and equipment associated with its construction. Completion itself was not stated.
  13. FY2022RaisedAnnual report

    「With regard to basic research, the company will use funds raised through the capital increase to strengthen its research structure and expand investment, including through construction of the new technology building, the MP Center, scheduled for completion in December 2022.」

    The company has expanded its plan to strengthen its basic research structure and increase investment into a specific facility plan: construction of the MP Center new technology building using funds from the capital increase.
  14. FY2022-Q3RestatedAnnual report

    「The total R&D expenses incurred by the Group during the first nine months of the current consolidated cumulative period amounted to ¥2,586 million. There were no material changes in the Group's R&D activities during the first nine months of the current consolidated cumulative period.」

    The company recorded R&D expenses of ¥2,586 million and reaffirmed that there were no material changes in its R&D activities.
  15. FY2022-Q2RestatedAnnual report

    「The total R&D expenses incurred by the Group during the first half of the current consolidated cumulative period amounted to ¥1,736 million. There were no material changes in the Group's R&D activities during the first half of the current consolidated cumulative period.」

    The company recorded R&D expenses of ¥1,736 million and reaffirmed that there were no material changes in its R&D activities.
  16. FY2022-Q1RestatedAnnual report

    「The total R&D expenses incurred by the Group during the first quarter of the current consolidated cumulative period amounted to ¥824 million. There were no material changes in the Group's R&D activities during the first quarter of the current consolidated cumulative period.」

    The company reaffirmed that there were no material changes in its R&D activities and disclosed first-quarter R&D expenses of ¥824 million.
  17. FY2021RaisedAnnual report

    「● Basic research The company will use funds raised through the capital increase to strengthen its basic research structure and expand investment in basic research, which will provide the foundation for long-term growth, focusing mainly on its strengths in micro-precision machining technology and microwave (high-frequency) technology.」

    In addition to its conventional R&D activities, the company has identified strengthening its basic research structure and expanding investment using funds raised through the capital increase as a long-term initiative. R&D expenses amounted to ¥3,201 million.
  18. FY2021-Q2RestatedAnnual report

    「The total R&D expenses incurred by the Group during the first half of the current consolidated cumulative period amounted to ¥1,652 million. There were no material changes in the Group's R&D activities during the first half of the current consolidated cumulative period.」

    The company recorded R&D expenses of ¥1,652 million and stated that there were no material changes in its R&D activities.
  19. FY2020RestatedAnnual report

    「Based on the Group's Companywide Growth Strategy, the Group has pursued R&D activities aimed at developing new technologies and products, with the R&D Department, the technology departments of the business divisions and local development centres working together. The focus has been on developing products with higher levels of technological integration and added value, centred on the Group's core technologies of antenna technology, semiconductor applications, microwave (high-frequency) technology, ceramics technology, micro-precision machining technology and photolithography (MEMS) technology.」

    The company continues to manage the R&D Department, the technology departments of the business divisions and local development centres in an integrated manner and to develop new technologies and products centred on its core technologies. R&D expenses amounted to ¥3,592 million.
  20. FY2020-Q3RestatedAnnual report

    「The total R&D expenses incurred by the Group during the first nine months of the current consolidated cumulative period amounted to ¥2,762 million. There were no material changes in the Group's R&D activities during the first nine months of the current consolidated cumulative period.」

    The company recorded R&D expenses of ¥2,762 million and stated that there were no material changes in its R&D activities.
  21. FY2020-Q2RestatedAnnual report

    「The total R&D expenses incurred by the Group during the first half of the current consolidated cumulative period amounted to ¥1,774 million. There were no material changes in the Group's R&D activities during the first half of the current consolidated cumulative period.」

    The company recorded R&D expenses of ¥1,774 million and stated that there were no material changes in its R&D activities.
  22. FY2019AdvancedAnnual report

    「The total R&D expenses incurred by the Group during the current consolidated fiscal year, including personnel expenses and other expenses, amounted to ¥3,260 million.」

    The company recorded R&D expenses of ¥3,260 million and continues to develop new technologies and products using its core technologies. It also states that development of the new LED package has been completed and full-scale mass production has begun.
  23. FY2019-Q2RestatedAnnual report

    「The total R&D expenses incurred by the Group during the first half of the current consolidated cumulative period amounted to ¥1,573 million. There were no material changes in the Group's R&D activities during the first half of the current consolidated cumulative period.」

    The company recorded R&D expenses of ¥1,573 million and reiterated that there were no material changes in its R&D activities.
  24. FY2019-Q1RestatedAnnual report

    「The total R&D expenses incurred by the Group during the first quarter of the current consolidated cumulative period amounted to ¥796 million. There were no material changes in the Group's R&D activities during the first quarter of the current consolidated cumulative period.」

    The company recorded R&D expenses of ¥796 million and stated that there were no material changes in its R&D activities.
  25. FY2018RestatedAnnual report

    「Based on the Group's Companywide Growth Strategy, the Group has pursued R&D activities aimed at developing new technologies and products, with the R&D Department, the technology departments of the business divisions and local development centres working together. The focus has been on developing products with higher levels of technological integration and added value, centred on the Group's core technologies of antenna technology, semiconductor applications, microwave (high-frequency) technology, ceramics technology, micro-precision machining technology and photolithography (MEMS) technology.」

    The company has reaffirmed its integrated management of the R&D Department, the technology departments of the business divisions and local development centres, as well as the development of new technologies and products centred on its core technologies.
  26. FY2018-Q3RestatedAnnual report

    「・Establishment of an integrated operating structure encompassing the technology departments of the business divisions, the Technology Headquarters and the R&D Department to accelerate the launch of strategic new products ・Promotion of open innovation with R&D institutions in Japan and overseas」

    The company has reiterated its integrated management of internal technology organisations and collaboration with R&D institutions in Japan and overseas. It also states that there have been no material changes in its R&D activities.
  27. FY2018-Q2RestatedAnnual report

    「・Establishment of an integrated operating structure encompassing the technology departments of the business divisions, the Technology Headquarters and the R&D Department to accelerate the launch of strategic new products ・Promotion of open innovation with R&D institutions in Japan and overseas」

    The company has reiterated its integrated management of internal technology organisations and collaboration with R&D institutions in Japan and overseas. It states that there have been no material changes in its R&D activities.
  28. FY2018-Q1RestatedAnnual report

    「・Establishment of an integrated operating structure encompassing the technology departments of the business divisions, the Technology Headquarters and the R&D Department to accelerate the launch of strategic new products ・Promotion of open innovation with R&D institutions in Japan and overseas」

    The company has reiterated its integrated management of internal technology organisations and collaboration with R&D institutions in Japan and overseas.
  29. FY2017-Q3RestatedAnnual report

    「Establishment of an integrated operating structure encompassing the technology departments of the business divisions, the Technology Headquarters and the R&D Department to accelerate the launch of strategic new products, and promotion of open innovation with R&D institutions in Japan and overseas」

    The company has reiterated its integrated management of internal technology organisations and collaboration with R&D institutions in Japan and overseas.
  30. FY2017-Q2RestatedAnnual report

    「Establishment of an integrated operating structure encompassing the technology departments of the business divisions, the Technology Headquarters and the R&D Department to accelerate the launch of strategic new products, and promotion of open innovation with R&D institutions in Japan and overseas」

    The company has reiterated its integrated management of internal technology organisations and collaboration with research institutions in Japan and overseas. It states that there have been no material changes in its R&D activities.
  31. FY2017-Q1First statedAnnual report

    「Establishment of an integrated operating structure encompassing the technology departments of the business divisions, the Technology Headquarters and the R&D Department to accelerate the launch of strategic new products, and promotion of open innovation with R&D institutions in Japan and overseas」

    The company uses integrated management of its internal technology organisations and collaboration with external research institutions to launch new products and businesses.
Moved together

"Transfer of production from the China plant to the Vietnam plant and use of EMS" moved the same way as this thread, in the same document, in 7 of its 31 moves.

766555★123456
  1. ★This thread
  2. 1Transfer of production from the China plant to the Vietnam plant and use of EMS7×
  3. 2Risk of foreign exchange losses due to yen appreciation6×
  4. 3Strengthening the Medical Device Assembly Business Through Proprietary Joining Technology6×
  5. 4Expansion into new fields for circuit-testing connectors and wireless communications equipment5×
  6. 5Fundamental Improvement in Fixed-Cost Efficiency and 24/7/365 Customer Support5×
  7. 6Strengthening Governance to Ensure Efficiency, Transparency and Legal Compliance5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Yokowo's next results are scheduled for 2026-11-10. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.